GleanMark

PROTEONANO Trademark

PROTEONANO is a USPTO trademark filed by Nanomics Biotechnology Co., Ltd.. Status: Registered.

Trademark Facts

MarkPROTEONANO
Serial Number99165555
Registration Number8192107
StatusRegistered
Filing Date2025-05-01
Registration Date2026-03-31
Mark TypeWord
Nice Classes001 (Chemicals)
OwnerNanomics Biotechnology Co., Ltd.
Attorney of RecordJustin Lampel
Prosecution Events17
Latest EventNRCC on 2026-03-31

Goods & Services

Laboratory apparatus and instruments for extracting proteomes, not for medical purposes; Laboratory consumables, namely, pipette tips; Laboratory robots; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Industrial automation controls; Pharmaceutical and scientific research equipment for use in mass spectrometers; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Laboratory apparatus and instruments, namely, pre-packed columns for use in separation and purification; Laboratory apparatus and chromatography systems for use in protein purification; Diagnostic reagents and preparations, except for medical or veterinary use; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Diagnostic preparations for research laboratory use; Polymer beads for use in manufacturing; Diagnostic preparations for scientific or research use other than for medical use; Reagents for scientific and research use; Biochemicals for in vitro and in vivo scientific use; Copolymer beads for use in manufacturing

Recent Prosecution Activity

DateDocumentType
2026-02-10OG Publication ConfirmationPB3
2026-02-04Notice of PublicationPB1
2026-02-04Notification of Notice of PublicationEB4
2026-01-14Examiner's AmendmentEXAMA
2026-01-14Amendment and Mail Process CompleteAMC
2026-01-14Public NotePNR

Related